Mind Medicine (MindMed) Inc. (MMED.NE) Comparison with companies in other sectors?

Mind Medicine (MindMed) Inc. has a share price of 70.50M. You can analyze Mind Medicine (MindMed) Inc. (MMED.NE) competitors across different market sectors through stock heatmaps.

What are MMED.NE's NET and operating margins?

Mind Medicine (MindMed) Inc. (MMED.NE) operating margin is around 0.00, and net profit margin is approximately 0.00 as of the latest reports.

In what way does MMED.NE's earnings per share (EPS) trend reflect its financial momentum?

Mind Medicine (MindMed) Inc. (MMED.NE) EPS is -3.31 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Mind Medicine (MindMed) Inc. is -4.50, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Mind Medicine (MindMed) Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Mind Medicine (MindMed) Inc. like P/E which is -4.50, P/B which is 2.78, and PEG which is 0.13. Compare them with sector averages to evaluate if the stock is priced fairly.

Mind Medicine (MindMed) Inc.

MMED.NE•NEO

Healthcare

Biotechnology

CA$14.90

CA$1.29(9.48%)

Mind Medicine (MindMed) Inc. (MMED.NE) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$-3.31

P/E Ratio

-4.50

ROE

-0.50%

Net Margin

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$1.05B

Shares OutstandingTotal number of shares issued

$70.50M

Book Value/ShareNet worth per share

$3.87

Revenue/ShareAnnual revenue per share

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-3.31

Net MarginNet income as percentage of revenue

Operating MarginOperating income as percentage of revenue

ROEReturn on shareholders' equity

-50.24%

ROAReturn on total assets

-43.20%

ROCEReturn on capital employed

-57.37%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-2.12

Cash/ShareCash and equivalents per share

$3.82

FCF YieldFree cash flow as percentage of market cap

-13.37%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for MMED.NEFinancial Ratios Analysis details for MMED.NE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for MMED.NESector Benchmarking details for MMED.NE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Mind Medicine (MindMed) Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Mind Medicine (MindMed) Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Mind Medicine (MindMed) Inc.'s unique business strengths and challenges.

Key Financial Metrics for Mind Medicine (MindMed) Inc.

For Mind Medicine (MindMed) Inc., essential financial indicators include EPS -3.31, PE -4.50, and ROE -0.50. These key ratios reveal insights into Mind Medicine (MindMed) Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Mind Medicine (MindMed) Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Mind Medicine (MindMed) Inc.

Metrics like Net Margin - and ROA -43.20% shed light on how well Mind Medicine (MindMed) Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Mind Medicine (MindMed) Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Mind Medicine (MindMed) Inc.

Using ratios such as P/B Ratio 2.78 and PEG Ratio 0.13, investors can assess whether Mind Medicine (MindMed) Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Mind Medicine (MindMed) Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Mind Medicine (MindMed) Inc.

Financial health indicators, such as Debt/Equity Ratio 0.22 and Cash Flow $-2.12, provide a snapshot of Mind Medicine (MindMed) Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Mind Medicine (MindMed) Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Mind Medicine (MindMed) Inc.

Investing in Mind Medicine (MindMed) Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Mind Medicine (MindMed) Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;